These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 29505194)

  • 21. Evaluation of the benefits of exercise on cognition in major depressive disorder.
    Greer TL; Furman JL; Trivedi MH
    Gen Hosp Psychiatry; 2017 Nov; 49():19-25. PubMed ID: 28690019
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Depression in Older Adults: A Treatable Medical Condition.
    Casey DA
    Prim Care; 2017 Sep; 44(3):499-510. PubMed ID: 28797375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Concurrent Koro and Cotard syndromes in a Spanish male patient with a psychotic depression and cerebrovascular disease.
    Alvarez P; Puente VM; Blasco MJ; Salgado P; Merino A; Bulbena A
    Psychopathology; 2012; 45(2):126-9. PubMed ID: 22310658
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contemporary methods of improving cognitive dysfunction in clinical depression.
    Knight MJ; Mills NT; Baune BT
    Expert Rev Neurother; 2019 May; 19(5):431-443. PubMed ID: 31020872
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cognitive impairment after depression leads to disability].
    Elliott AF; Hell MD; Sheldrick-Michel A; Nielsen B
    Ugeskr Laeger; 2016 Nov; 178(45):. PubMed ID: 27855769
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The impact of cognitive challenges in major depression: the role of the primary care physician.
    Mattingly G; Anderson RH; Mattingly SG; Anderson EQ
    Postgrad Med; 2016 Sep; 128(7):665-71. PubMed ID: 27500820
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of levomilnacipran extended-release on major depressive disorder patients with cognitive impairments: post-hoc analysis of a phase III study.
    Wesnes KA; Gommoll C; Chen C; Sambunaris A; McIntyre RS; Harvey PD
    Int Clin Psychopharmacol; 2017 Mar; 32(2):72-79. PubMed ID: 27861191
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cognitive component of psychomotor retardation in unipolar and bipolar depression: Is verbal fluency a relevant marker? Impact of repetitive transcranial stimulation.
    Thomas-Ollivier V; Foyer E; Bulteau S; Pichot A; Valriviere P; Sauvaget A; Deschamps T
    Psychiatry Clin Neurosci; 2017 Sep; 71(9):612-623. PubMed ID: 28419623
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of Intensive Short-Term Dynamic Psychotherapy on Depressive Symptoms and Executive Functioning in Major Depression.
    Ajilchi B; Nejati V; Town JM; Wilson R; Abbass A
    J Nerv Ment Dis; 2016 Jul; 204(7):500-5. PubMed ID: 27065106
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systematic reviews of randomised clinical trials examining the effects of psychotherapeutic interventions versus "no intervention" for acute major depressive disorder and a randomised trial examining the effects of "third wave" cognitive therapy versus mentalization-based treatment for acute major depressive disorder.
    Jakobsen JC
    Dan Med J; 2014 Oct; 61(10):B4942. PubMed ID: 25283628
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improving patient outcomes in depression through guideline-concordant, measurement-based care.
    Culpepper L
    J Clin Psychiatry; 2013 Apr; 74(4):e07. PubMed ID: 23656851
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multidimensional cognitive impairment in unipolar and bipolar depression and the moderator effect of adverse childhood experiences.
    Poletti S; Aggio V; Brioschi S; Dallaspezia S; Colombo C; Benedetti F
    Psychiatry Clin Neurosci; 2017 May; 71(5):309-317. PubMed ID: 28004481
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Measuring cognitive function in MDD: emerging assessment tools.
    Russo M; Mahon K; Burdick KE
    Depress Anxiety; 2015 Apr; 32(4):262-9. PubMed ID: 25421437
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anxiety and Depression as Longitudinal Predictors of Mild Cognitive Impairment in Older Adults.
    Freire ACC; Pondé MP; Liu A; Caron J
    Can J Psychiatry; 2017 May; 62(5):343-350. PubMed ID: 28346831
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Altered fractional amplitude of low frequency fluctuation associated with cognitive dysfunction in first-episode drug-naïve major depressive disorder patients.
    Huang M; Lu S; Yu L; Li L; Zhang P; Hu J; Zhou W; Hu S; Wei N; Huang J; Weng J; Xu Y
    BMC Psychiatry; 2017 Jan; 17(1):11. PubMed ID: 28077120
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytokine alterations and cognitive impairment in major depressive disorder: From putative mechanisms to novel treatment targets.
    Misiak B; Beszłej JA; Kotowicz K; Szewczuk-Bogusławska M; Samochowiec J; Kucharska-Mazur J; Frydecka D
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jan; 80(Pt C):177-188. PubMed ID: 28433456
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cognitive dysfunction in major depressive disorder.
    Knight MJ; Baune BT
    Curr Opin Psychiatry; 2018 Jan; 31(1):26-31. PubMed ID: 29076892
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Using measurement strategies to identify and monitor residual symptoms.
    McIntyre RS
    J Clin Psychiatry; 2013; 74 Suppl 2():14-8. PubMed ID: 24191973
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cognitive predictors of illness course at 12 months after first-episode of depression.
    Vicent-Gil M; Keymer-Gausset A; Serra-Blasco M; Carceller-Sindreu M; de Diego-Adeliño J; Trujols J; Mur M; Pérez V; Alvarez E; Cardoner N; Portella MJ
    Eur Neuropsychopharmacol; 2018 Apr; 28(4):529-537. PubMed ID: 29482974
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transcranial Magnetic Stimulation (TMS) in the Elderly.
    Iriarte IG; George MS
    Curr Psychiatry Rep; 2018 Feb; 20(1):6. PubMed ID: 29427050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.